60 Recruiting Studies Using Busulfan
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Busulfan
Itacitinib for the Prevention of Graft Versus Host Disease
📍 M D Anderson Cancer Center — Houston, Texas
Hematologic and Lymphocytic Disorder
View Study & Checklist ➔Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Chronic Granulomatous Disease
View Study & Checklist ➔Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
📍 City of Hope Medical Center — Duarte, California
AIDS-related Non-Hodgkin Lymphoma
View Study & Checklist ➔Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
📍 Masonic Cancer Center, University of Minnesota — Minneapolis, Minnesota
SCID
View Study & Checklist ➔A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Acute Myeloid Leukemia (AML)
View Study & Checklist ➔Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
Acute Myeloid Leukemia (AML)
View Study & Checklist ➔Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
DOCK8 Deficiency
View Study & Checklist ➔Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Primary Myelofibrosis
View Study & Checklist ➔High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Chronic Granulomatous Disease Transplant
View Study & Checklist ➔Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
📍 M D Anderson Cancer Center — Houston, Texas
Hematopoietic and Lymphoid Cell Neoplasm
View Study & Checklist ➔HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
📍 City of Hope National Medical Center — Duarte, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Conditioning SCID Infants Diagnosed Early
📍 Univeristy of Alabama at Birmingham — Birmingham, Alabama
SCID
View Study & Checklist ➔Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
📍 Masonic Cancer Center at University of Minnesota — Minneapolis, Minnesota
Acute Myeloid Leukemia
View Study & Checklist ➔Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Hematologic Malignancies
View Study & Checklist ➔Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes
📍 University of Illinois at Chicago — Chicago, Illinois
Acute Myeloid Leukemia
View Study & Checklist ➔Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)
📍 St. Jude Children's Research Hospital — Memphis, Tennessee
Severe Combined Immunodeficiency
View Study & Checklist ➔HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis
📍 Mayo Clinic Arizona — Phoenix, Arizona
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
📍 M D Anderson Cancer Center — Houston, Texas
Acute Myeloid Leukemia
View Study & Checklist ➔Optimizing PTCy Dose and Timing
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Graft Versus Host Disease
View Study & Checklist ➔Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
📍 M D Anderson Cancer Center — Houston, Texas
Recurrent Acute Myeloid Leukemia
View Study & Checklist ➔A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)
📍 Palo Verde Hematology/ Oncology Center, Ltd. ( Site 3496) — Glendale, Arizona
Essential Thrombocythemia
View Study & Checklist ➔Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
📍 Children's Hospital of Alabama — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple Myeloma
📍 University of California Davis Comprehensive Cancer Center — Sacramento, California
Recurrent Multiple Myeloma
View Study & Checklist ➔26DT052; Scaling Busulfan Dose to Body Surface Area in Children
📍 Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
Busulfan Pharmacokinetic Analysis
View Study & Checklist ➔Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Core Binding Factor Alpha Subunits
View Study & Checklist ➔Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
WHIM
View Study & Checklist ➔Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome
📍 University of Michigan Rogel Cancer Center — Ann Arbor, Michigan
Acute Myeloid Leukemia
View Study & Checklist ➔CD34+ Transplants for Leukemia and Lymphoma
📍 Baptist Health South Florida/Miami Cancer Institute — Miami, Florida
Leukemia, Myeloid, Acute
View Study & Checklist ➔Personalized NK Cell Therapy in CBT
📍 M D Anderson Cancer Center — Houston, Texas
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
View Study & Checklist ➔Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
📍 City of Hope Medical Center — Duarte, California
Acute Myeloid Leukemia
View Study & Checklist ➔Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
X-linked Severe Combined Immunodeficiency (XSCID)
View Study & Checklist ➔Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
📍 Masonic Cancer Center, University of Minnesota — Minneapolis, Minnesota
Hematologic Disorders
View Study & Checklist ➔A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Immunodeficiency
View Study & Checklist ➔Umbilical Cord Blood Transplantation From Unrelated Donors
📍 Wilmot Cancer Institute — Rochester, New York
Acute Leukemia
View Study & Checklist ➔HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Fanconi Anemia
View Study & Checklist ➔Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)
📍 University of Illinois Cancer Center — Chicago, Illinois
Acute Myeloid Leukemia, Relapsed, Adult
View Study & Checklist ➔Allo HSCT for High Risk Hemoglobinopathies
📍 Masonic Cancer Center — Minneapolis, Minnesota
Graft Failure
View Study & Checklist ➔MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
📍 University of Minnesota Masonic Cancer Center — Minneapolis, Minnesota
Hematologic Malignancy
View Study & Checklist ➔Cord Blood Transplantation in Children and Young Adults With Blood Cancer
📍 Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York
Acute Myelogenous Leukemia
View Study & Checklist ➔Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
📍 Children's Hospital of Alabama — Birmingham, Alabama
Ganglioneuroblastoma
View Study & Checklist ➔Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma
📍 MD Anderson Cancer Center — Houston, Texas
Multiple Myeloma
View Study & Checklist ➔Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
📍 Hospital de Pediatria "Juan P. Garrahan" Combate de Los Pozos N°1800 CABA — Buenos Aires,
Acute Lymphoblastic Leukaemia
View Study & Checklist ➔Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
📍 Memorial Sloan Kettering Cancer Center — New York, New York
AML
View Study & Checklist ➔Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
📍 UMPC Hillman Cancer Center — Pittsburgh, Pennsylvania
Acute Lymphocytic Leukemia (ALL)
View Study & Checklist ➔Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
📍 Masonic Cancer Center at University of Minnesota — Minneapolis, Minnesota
Fanconi Anemia
View Study & Checklist ➔Autologous Gene Therapy for Artemis-Deficient SCID
📍 University of California, San Francisco (UCSF) Children's Hospital — San Francisco, California
Severe Combined Immunodeficiency
View Study & Checklist ➔Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Chronic Granulomatous Disease (CGD)
View Study & Checklist ➔Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
📍 Children's Hospital of Los Angeles — Los Angeles, California
Acute Biphenotypic Leukemia
View Study & Checklist ➔Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
GATA2
View Study & Checklist ➔Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
📍 M D Anderson Cancer Center — Houston, Texas
Acute Myeloid Leukemia
View Study & Checklist ➔Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Chronic Granulomatous Disease
View Study & Checklist ➔Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Lymphoproliferative Disorders
View Study & Checklist ➔Gene Editing For Sickle Cell Disease
📍 St. Jude Children's Research Hospital — Memphis, Tennessee
Sickle Cell Disease
View Study & Checklist ➔Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Myelodysplastic/Myeloproliferative Neoplasm
View Study & Checklist ➔MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Acute Myeloid Leukemia
View Study & Checklist ➔Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Hematologic Neoplasms
View Study & Checklist ➔Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML
📍 Washington University School of Medicine — St Louis, Missouri
AML, Childhood
View Study & Checklist ➔Base Editing Hematopoietic Stem Cell and T Cell Gene Therapy for CD40L-HyperIgM Syndrome: Single Patient Study
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
CD40L-HyperIgM Syndrome
View Study & Checklist ➔Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
📍 Moffitt Cancer Center — Tampa, Florida
Acute Leukemia
View Study & Checklist ➔High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
📍 MD Anderson Cancer Center — Houston, Texas
Splenomegaly
View Study & Checklist ➔